Polar Asset Management Partners Inc. Boosts Stock Holdings in STAAR Surgical (NASDAQ:STAA)

Polar Asset Management Partners Inc. raised its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 44.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 168,800 shares of the medical instruments supplier's stock after buying an additional 51,800 shares during the period. Polar Asset Management Partners Inc. owned about 0.34% of STAAR Surgical worth $6,271,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in STAA. Van ECK Associates Corp grew its holdings in STAAR Surgical by 12.7% during the 3rd quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier's stock worth $129,000 after acquiring an additional 393 shares during the period. Sei Investments Co. boosted its position in shares of STAAR Surgical by 2.7% during the 2nd quarter. Sei Investments Co. now owns 15,087 shares of the medical instruments supplier's stock valued at $718,000 after purchasing an additional 394 shares in the last quarter. Creative Planning grew its stake in STAAR Surgical by 8.0% during the third quarter. Creative Planning now owns 5,524 shares of the medical instruments supplier's stock worth $205,000 after purchasing an additional 408 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in STAAR Surgical by 3.8% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 11,343 shares of the medical instruments supplier's stock worth $540,000 after purchasing an additional 418 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its stake in STAAR Surgical by 2.3% in the second quarter. Linden Thomas Advisory Services LLC now owns 20,721 shares of the medical instruments supplier's stock valued at $987,000 after buying an additional 469 shares during the period. 96.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on STAA. Canaccord Genuity Group reduced their price objective on shares of STAAR Surgical from $41.00 to $31.00 and set a "hold" rating for the company in a research report on Friday, November 1st. Stephens upgraded shares of STAAR Surgical to a "hold" rating in a report on Monday. Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a report on Thursday, October 31st. Finally, Stifel Nicolaus decreased their target price on STAAR Surgical from $50.00 to $44.00 and set a "buy" rating for the company in a research report on Monday, August 26th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $43.33.

STAAR Surgical Trading Down 2.7 %

Shares of STAA traded down $0.71 on Thursday, reaching $25.24. The company's stock had a trading volume of 473,220 shares, compared to its average volume of 705,246. STAAR Surgical has a twelve month low of $25.15 and a twelve month high of $52.68. The stock has a market capitalization of $1.24 billion, a PE ratio of 57.36 and a beta of 0.59. The firm has a fifty day moving average of $30.31 and a 200-day moving average of $35.77.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.